Tremor

Overview

Category: Motor symptom (Cardinal symptoms)

Prevalence: 70% at diagnosis

Detailed Information

Resting tremor occurs when muscles are relaxed and typically decreases during voluntary movement. The tremor usually begins unilaterally -- most often in one hand -- and may eventually affect both sides of the body, as well as the legs, jaw, and chin. It is present in about 70% of people with PD at diagnosis. While resting tremor is the hallmark, action tremor (occurring during voluntary movement) and postural tremor (occurring when holding a position against gravity) can also occur in PD. Re-emergent tremor -- a postural tremor that appears after a latency of several seconds -- is relatively specific to PD. Tremor tends to worsen with stress, fatigue, strong emotions, and cognitive tasks such as mental arithmetic. Importantly, tremor severity does not correlate well with disease progression; some patients with severe tremor have relatively slow overall disease advancement.

Pathophysiology: Why This Happens

Parkinsonian tremor originates from abnormal oscillatory activity within the basal ganglia-thalamocortical circuit. The loss of dopaminergic neurons in the substantia nigra pars compacta disrupts the normal balance between the direct and indirect pathways of the basal ganglia, leading to pathological oscillations. The ventral intermediate (VIM) nucleus of the thalamus and the subthalamic nucleus (STN) are key nodes in generating tremor.

Electrophysiological studies demonstrate coherent oscillatory activity at 4-6 Hz between the basal ganglia, thalamus, cerebellum, and motor cortex in tremor-dominant PD. The cerebello-thalamo-cortical circuit is increasingly recognized as playing a central role -- cerebellar activity may serve as a compensatory mechanism or may drive tremor through aberrant coupling with the basal ganglia. Unlike bradykinesia and rigidity, tremor does not correlate linearly with the degree of nigrostriatal dopamine depletion, suggesting additional non-dopaminergic mechanisms involving serotonergic and noradrenergic pathways.

Prevalence and Demographics

Tremor is present at diagnosis in approximately 70% of PD patients and develops in up to 75% over the course of the disease. The tremor-dominant subtype of PD accounts for roughly 70% of cases and is associated with slower disease progression and less cognitive decline compared to the postural instability/gait difficulty (PIGD) subtype. Resting tremor prevalence increases with age in the general PD population but is paradoxically more common as a presenting symptom in younger-onset PD.

Men and women are affected at comparable rates within the PD population, though PD itself is 1.5 times more common in men. Ethnicity data are limited, but U.S.-based studies suggest similar tremor prevalence across racial groups among those with confirmed PD. Worldwide, nearly 90,000 people are diagnosed with PD annually in the United States alone, with the majority presenting with tremor as a leading symptom.

Differential Diagnosis

Several other conditions can cause similar symptoms. A thorough medical evaluation is essential to distinguish Parkinson's-related tremor from other causes:

Essential tremor (ET) is the most common condition confused with parkinsonian tremor. ET typically produces a bilateral postural and kinetic tremor at 4-12 Hz, often improving with alcohol and worsening with action -- the opposite pattern of PD resting tremor. However, overlap exists: up to 20% of ET patients may develop PD features. A DaTscan (dopamine transporter SPECT imaging) can help distinguish PD from ET by demonstrating reduced striatal dopamine transporter binding in PD.

Other conditions in the differential include drug-induced parkinsonism (antipsychotics, metoclopramide, valproic acid), enhanced physiological tremor (thyrotoxicosis, caffeine excess, anxiety, medication side effects), Wilson's disease (in patients under 40), dystonic tremor, and functional (psychogenic) tremor. Functional tremor characteristically changes frequency with distraction or contralateral movement entrainment. Rare causes include fragile X-associated tremor/ataxia syndrome (FXTAS) and Holmes tremor following midbrain lesions.

How This Symptom Changes by Stage

In early PD (Hoehn and Yahr stages 1-2), tremor typically begins in one hand, often intermittently, and may appear only during stress or fatigue. Many patients first notice tremor at rest -- for example, while watching television or sitting with hands in the lap. At this stage, tremor usually disappears with purposeful movement.

As the disease progresses to stages 2-3, tremor typically spreads to the ipsilateral leg and then to the contralateral side. The amplitude may increase and tremor becomes more persistent. Action and postural tremor components may emerge alongside the resting tremor.

In stages 4-5, tremor may paradoxically diminish in some patients as akinesia and rigidity become more dominant; in others, tremor remains prominent. Medication response evolves over time: early-stage tremor often responds well to dopaminergic therapy, but as the disease advances, tremor may become relatively resistant to levodopa, sometimes requiring anticholinergics, amantadine, or consideration of deep brain stimulation.

Stage-by-Stage Quick Reference

A summary of how tremor typically presents at each Hoehn & Yahr stage:

Stage 1

May appear in one hand

Stage 2

Affects both hands

Stage 3

Can affect legs and jaw

Stage 4

More pronounced

Stage 5

Severe, continuous

Management Strategies

Pharmacological management begins with dopaminergic medications. Levodopa/carbidopa remains the most effective first-line treatment for most PD motor symptoms including tremor. Dopamine agonists (pramipexole, ropinirole) may provide adequate tremor control, particularly in younger patients. Anticholinergic medications (trihexyphenidyl, benztropine) can be effective specifically for tremor but carry significant cognitive side effects and are generally avoided in patients over 65. MAO-B inhibitors (rasagiline, safinamide) may provide modest tremor benefit as monotherapy or adjunctive treatment.

For medically refractory tremor, deep brain stimulation (DBS) targeting the subthalamic nucleus or ventral intermediate nucleus of the thalamus is the most effective intervention, with sustained tremor reduction of 70-90% in long-term studies. MR-guided focused ultrasound thalamotomy is a noninvasive alternative approved for tremor-dominant PD, achieving unilateral tremor reduction without surgery.

Non-pharmacological approaches include adaptive devices (weighted utensils, stabilizing spoons), stress reduction techniques, adequate sleep, limiting caffeine, and regular exercise. Occupational therapy can help patients develop compensatory strategies for daily activities affected by tremor.

Practical Tips

• Take medications on schedule
• Reduce caffeine intake
• Practice stress-reduction techniques
• Use weighted utensils for eating
• Consider occupational therapy for adaptive strategies

When to See a Doctor

If tremor suddenly worsens, spreads rapidly to new body parts, or is accompanied by other neurological symptoms.

The Bigger Picture

Tremor occupies a unique position among PD symptoms: it is the most publicly visible and socially stigmatizing motor feature, yet paradoxically it is often the least disabling in functional terms compared to bradykinesia and postural instability. Many patients describe the psychological burden of tremor -- embarrassment in social settings, assumptions of frailty by strangers -- as more distressing than the physical limitation itself.

It is also worth noting that tremor-dominant PD generally carries a more favorable long-term prognosis, with slower cognitive decline and slower overall disease progression compared to the PIGD subtype. This information, when communicated sensitively, can provide meaningful reassurance to newly diagnosed patients. However, individual prognosis varies widely, and no subtype classification should be treated as deterministic.